Outcomes | Pooled outcome | № of participants (studies) | Quality of the evidence (GRADE) | Comments |
---|---|---|---|---|
Survival | ||||
Survival follow up: 1 months | 34 (51.5%; range 33.3–61.9%) | ⨁⨁◯◯ LOW a | ||
Survival follow up: 6 months | 9 (42.9%) | 21 (1 observational study) [44] | ⨁◯◯◯ VERY LOW a,b | |
Survival follow up: 12 months | 7 (33.3%) | 21 (1 observational study) [44] | ⨁◯◯◯ VERY LOW a,b | |
AIDS specific mortality | No studies reported AIDS specific mortality at any point | |||
VPS survival | No studies reported VPS failure or survival rates at any time point | |||
Operative complication | No studies reported rates of operative complication at any time point | |||
Validated outcome score | ||||
Glasgow outcome score (GOS) follow up: 1 month | GOS 1–3: 26 (57.8%) GOS 4–5: 19 (42.2%) | ⨁⨁◯◯ LOW a | GOS 1–3 signifies death to severe disability GOS 4–5 signifies moderate to low disability | |
Glasgow outcome score (GOS) follow up: 6 months | GOS 1–3: 16 (76.2%) GOS 4–5: 5 (23.8%) | 21 (1 observational study) [46] | ⨁◯◯◯ VERY LOW a,c | GOS 1–3 signifies death to severe disability GOS 4–5 signifies moderate to low disability |
Glasgow outcome score (GOS) follow up: 12 months | No studies reported a validated outcome score at 12 months |